Akebia Ther
Price & Volume
Stats
See moreOpen | $1.40 |
Previous Close | $1.40 |
Day Range | $1.36-$1.40 |
52W Range | $0.82-$4.04 |
Market Cap | $375.5M |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $232.4M |
Revenue Growth (YoY) | -6.6% |
Gross Profit (12 Mos) | $190.4M |
Diluted EPS | -$0.08 |
News
See moreYahoo Finance • 13 days ago
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 15 days ago
Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036
Yahoo Finance • 2 months ago
Akebia outlines Phase II FSGS study of up to ~60 patients as Vafseo reaches nearly 7,500 patients
Yahoo Finance • 2 months ago
Akebia plunges 20% on muted Q1 print
About
CEO | Mr. John P. Butler MBA |
CFO | Mr. Erik John Ostrowski M.B.A. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 194 |